Gene · 1616
DAXX: death domain associated protein
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. DAXX: death domain associated protein. Genes, record 1616. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/1616
On this page
Gene
Proteins1
Reviewed human proteins whose Swiss-Prot entry states the gene.
| UniProt entry | Protein | Length | Structures | Gene stated in |
|---|---|---|---|---|
| Q9UER7 | Death domain-associated protein 6 | 740 | 14 | Ensembl, GeneID, HGNC |
Source UniProt
Patents158
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
| Publication | Published | SEQ ID NO | Protein | Source |
|---|---|---|---|---|
| WO 2026219974 A1 | 2026-10-22 | 2 | Q9UER7 | Espacenet |
| EP 4691494 A1 | 2026-02-11 | 6 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43411 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43412 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43413 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43414 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43421 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43422 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43425 | Q9UER7 | Espacenet |
| JP 2026004568 A | 2026-01-14 | 43429 | Q9UER7 | Espacenet |
1 to 10 of 158
See all 158 patentsDrugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants2,149
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | DAXX papers | Newest fiscal year |
|---|---|---|---|
| P30CA008748 | Cancer Center Support Grant | 57 | 2025 |
| P30CA010815 | Consolidated Basic Cancer Research Program | 34 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 31 | 2025 |
| P30CA006973 | Regional Oncology Research Center | 22 | 2025 |
| P30CA021765 | Cancer Center Support Grant (CCSG) | 17 | 2025 |
| P30CA047904 | Cancer Center Support Grant | 11 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 9 | 2025 |
| P30CA086862 | Cancer Center Support Grant | 9 | 2025 |
| T32CA009110 | Training in Areas Fundamental to Cancer Research | 9 | 2025 |
| P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 8 | 2025 |
1 to 10 of 2,149Source NIH's project files
See all 2,149 nih grantsPapers3,633
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Exploring Molecular Pathways in Metastasis of Breast Cancer Cells to the Brain: Insights from Gene Expression Analysis and Cellular Origins. | J Microsc Ultrastruct | 2026 | 42824931 | PubTator, text mining | PubMed |
| The Genomic Patterns of Well-Differentiated Pancreatic Neuroendocrine Tumors (NETs) Identify Sub-Sets for Rational Therapeutic Targeting. | Int J Mol Sci | 2026 | 42794433 | PubTator, text mining | PubMed |
| Daxx depletion remodels silent rDNA chromatin and increases UBF-bound transcriptional potential. | Biochem Biophys Res Commun | 2026 | 42759275 | PubTator, text mining | PubMed |
| A comprehensive survey of genetic variants in neuroblastoma. | J Genet Eng Biotechnol | 2026 | 42749408 | PubTator, text mining | PubMed |
| Deconstructing the Alternative Lengthening of Telomeres: Integromics Prioritizes Five Master Hubs Dictating Clinical Survival and Therapeutic Vulnerabilities. | Biology (Basel) | 2026 | 42737963 | PubTator, text mining | PubMed |
| Comprehensive Somatic Profiling of Gastroenteropancreatic Neuroendocrine Neoplasms. | Endocr Oncol | 2026 | 42725815 | PubTator, text mining | PubMed |
| Mast cell leukemia with complex genomic alterations in an elderly patient with prior hematologic and solid malignancies: a case report. | Ann Med Surg (Lond) | 2026 | 42724865 | PubTator, text mining | PubMed |
Real-World-Feasible Immunohistochemistry of ATRX, DAXX, and Menin Identifies a Subgroup of Non-Functioning Pancreatic Neuroendocrine Tumors with low Recurrence Risk to Guide De-Escalating Surveillance. | Endocr Pathol | 2026 | 42667492 | PubTator, text mining | PubMed |
| PSIP1::TBL1X: a recurrent gene fusion in pancreatic neuroendocrine tumors. | Endocr Relat Cancer | 2026 | 42659417 | PubTator, text mining | PubMed |
| Microglia activation by derepression of endogenous retroviruses drives inflammation and cellular senescence. | Nat Neurosci | 2026 | 42608571 | PubTator, text mining | PubMed |
1 to 10 of 3,633
See all 3,633 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/1616
GET https://conductscience.org/api/genes/v1/1616/patents?page=2